Associated Papers
GBA1-Associated Parkinson's Disease Is a Distinct Entity.
Skrahin A et al.
International Journal of Molecular Sciences, 2024
Differential effects of Mendelian GDAP1 clinical variants on mitochondria-lysosome membrane contacts sites.
Cantarero L et al.
Biology Open, 2023
Genetic Architecture of Parkinson's Disease.
Shadrina MI et al.
Biochemistry. Biokhimiia, 2023
Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications.
Balestrino R et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry, 2018
An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease.
Török R et al.
Neuroscience Letters, 2016
Genetic assessment of familial and early-onset Parkinson's disease in a Greek population.
Bozi M et al.
European Journal of Neurology, 2014
Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS.
Bendikov-Bar I et al.
Orphanet Journal of Rare Diseases, 2014
Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease.
Li Y et al.
Neurobiology of Aging, 2014
The neuropathology of genetic Parkinson's disease.
Poulopoulos M et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2012
Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson's disease in Taiwan.
Huang CL et al.
European Journal of Neurology, 2011
The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders.
Velayati A et al.
Current Neurology and Neuroscience Reports, 2010
The role of mitochondrial network dynamics in the pathogenesis of Charcot-Marie-Tooth disease.
Palau F et al.
Advances in Experimental Medicine and Biology, 2009
Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese.
Wu YR et al.
Journal of Neurology, Neurosurgery, and Psychiatry, 2007